MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
112.87
-1.99
-1.73%
After Hours: 112.87 0 0.00% 16:33 07/18 EDT
OPEN
115.18
PREV CLOSE
114.86
HIGH
115.34
LOW
112.16
VOLUME
564.07K
TURNOVER
--
52 WEEK HIGH
148.06
52 WEEK LOW
95.49
MARKET CAP
6.83B
P/E (TTM)
15.05
1D
5D
1M
3M
1Y
5Y
1D
Jazz Pharmaceuticals’ Phase 4 Study on Epidiolex: A Potential Game-Changer for Tuberous Sclerosis Complex
TipRanks · 1d ago
Analysts’ Top Healthcare Picks: Jazz Pharmaceuticals (JAZZ), Abbott Laboratories (ABT)
TipRanks · 1d ago
Jazz Pharmaceuticals’ Promising Study on Zanidatamab for Breast Cancer
TipRanks · 2d ago
Jazz Pharmaceuticals’ XYWAV Study: A Potential Game-Changer for Sleep Disorders
TipRanks · 2d ago
XPH: Healthcare Dashboard For July
Seeking Alpha · 4d ago
Jazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in Breast Cancer Treatment?
TipRanks · 4d ago
Deutsche starts Jazz with Buy into period of value creation
TipRanks · 4d ago
Jazz Pharmaceuticals initiated with a Buy at Deutsche Bank
TipRanks · 4d ago
More
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.